Sat, 24 Feb 2024 08:00:00 GMT

Arthur Collins, a director at Aflac Inc (NYSE:AFL), executed a sale of 3,000 shares in the company on February 22, 2024, according to a recent SEC Filing. Aflac Inc is known for providing supplemental health and life insurance products. It operates through its subsidiaries, offering a range of insurance policies which include accident, short-term disability, critical illness, life insurance, and other types of coverage that help protect individuals and families.

Over the past year, the insider has sold a total of 3,000 shares and has not made any purchases of the company's stock.

The transaction history for insiders at Aflac Inc indicates a trend of more insider selling than buying over the past year. There have been 23 insider sells and only 2 insider buys during this period.

On the date of the insider's recent transaction, shares of Aflac Inc were priced at $79.73, resulting in a market capitalization of $46,397.240 million.

The price-earnings ratio of Aflac Inc stands at 10.38, which is below the industry median of 12.18 but above the company's historical median price-earnings ratio.

Aflac Inc's stock, with a trading price of $79.73 and a GuruFocus Value of $56.95, has a price-to-GF-Value ratio of 1.4, indicating that the stock is Significantly Overvalued according to its GF Value.

The GF Value is calculated by GuruFocus and takes into account historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's past returns and growth, and future business performance estimates from Morningstar analysts.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.